Latest News of MICS
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now
A list of top genomics stocks includes Fulgent Genetics, Inc. The genomics field is rapidly growing due to technological advancements reducing costs and time for genome mapping. Experts like Cathie Wo...
CRISPR Therapeutics AG (CRSP): Among the Best Genomics Stocks to Buy Right Now
Discover the top Genomics stocks to invest in now, including CRISPR Therapeutics AG. Genomics is a growing field with companies leveraging technological advancements to revolutionize gene studies. Exp...
Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
A list of top genomics stocks includes Biogen Inc. (NASDAQ:BIIB). Genomics sector is rapidly growing due to technological advancements reducing costs and time to map genomes. Investors like Cathie Woo...
-
Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
By Yahoo! Finance | 3 days agoA list of top genomics stocks includes Ionis Pharmaceuticals, Inc. as a leading contender. Genomics is growing rapidly with reduced costs and time to map genomes. Cathie Wood highlights the Genomic Re...
-
BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now
By Yahoo! Finance | 3 days agoThe article discusses the growing importance of genomics stocks in the market, highlighting BioMarin Pharmaceutical Inc. and the potential of the genomics industry. Cathie Wood emphasizes the revoluti...
-
Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
By Yahoo! Finance | 3 days agoThe global genomics market is expanding rapidly due to factors like personalized treatment, gene therapy, and rising cancer rates. The pharmaceutical sector dominated in 2023, with North America leadi...
-
Exact Sciences Corporation (EXAS): Among the Best Genomics Stocks to Buy Right Now
By Yahoo! Finance | 3 days agoThe global genomics market is projected to grow at a 16.5% rate from 2024 to 2030, driven by factors like personalized treatment demand, gene therapy, and rising cancer rates....
-
I quit my finance job to pursue my dream of writing comics. I used a pitch deck to convince my parents it was a good idea.
By Business Insider | 1 week agoBrandon Chen, a successful webcomic author, transitioned from a finance job to full-time writing after gaining recognition on platforms like Webtoon. His journey, influenced by a childhood love for co...
-
Capital Dynamics secures £48.5m funding for Scottish onshore wind farm
By Yahoo! Finance | 1 week agoCapital Dynamics secures £48.5m funding for Scottish onshore wind projects with a total capacity of 193MW. The funding comes from Border to Coast Pensions Partnership for the Clean Energy UK Fund, su...
-
Commentary: This week in Bidenomics: See ya!
By Yahoo! Finance | 2 weeks agoVoters expressed dissatisfaction with the Biden economy, citing issues like inflation. Trump's win highlighted Americans' concerns about wokeism, big government, and migration. Despite some economic p...
-
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
By Yahoo! Finance | 2 weeks agoBecton, Dickinson and Company reported strong fourth-quarter sales, exceeding expectations. The company is focusing on higher-growth areas and innovation to enhance patient care. BD projects growth an...
-
Stocks Showing Improving Market Leadership: Steel Dynamics Earns 83 RS Rating
By Investor's Business Daily | 2 weeks agoInvestor's Business Daily's Market Breadth indicator rates stocks from 1 to 99. Stocks with an RS Rating above 80 tend to show significant gains. Steel Dynamics stock is out of buy range after a cup-w...
-
Why quant giant D.E. Shaw seeks out academics, doctors, and veterans to work at the $60 billion hedge fund
By Business Insider | 2 weeks agoAfter pursuing a career in academia, Tim Willenken shifted to corporate development at D.E. Shaw, a secretive hedge fund. The firm values diverse backgrounds and offers robust training. Its hiring pro...
-
Singular Genomics Shares Soar After Deerfield Increases Acquisition Offer
By MarketWatch | 2 weeks agoSingular Genomics Systems' shares surged following Deerfield Management's increased acquisition proposal. The stock price rose 60% to $21.60, with Deerfield offering $24 per share. Negotiations are on...
-
Did Bidenomics work? How the US economy fared over the last four years
By The Guardian | 3 weeks agoPresident Joe Biden inherited a struggling US economy hit by Covid and rising inflation. Despite initial fears, the economy remained resilient under his leadership, with job creation and steady growth...